Lynne Zydowsky - Jun 2, 2021 Form 4 Insider Report for YUMANITY THERAPEUTICS, INC. (KA)

Role
Director
Signature
/s/ Marie Epstein, Attorney-in-Fact
Stock symbol
KA
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 04:05 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award $0 +14.8K $0.00 14.8K Jun 2, 2021 Common Stock 14.8K $15.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in equal quarterly installments over three years following June 2, 2021.